T cells specific to hapten carrier but not to carrier alone assist in the production of anti-hapten and anti-carrier antibodies.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 17881502)

Published in Int Immunol on September 19, 2007

Authors

Takeyuki Shimizu1, Yuko Osaka, Chihiro Banri-Koike, Maiko Yoshida, Kanako Endo, Koji Furukawa, Masayuki Oda, Akikazu Murakami, Shuhei Ogawa, Ryo Abe, Takachika Azuma

Author Affiliations

1: Division of Structural Immunology, Research Institute for Biological Sciences, Tokyo University of Science, Yamazaki 2669, Noda, Chiba 278-0022, Japan.

Articles by these authors

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol (2009) 12.13

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci U S A (2004) 3.23

Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J (2005) 3.14

Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus. J Virol (2005) 1.72

TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice. J Clin Invest (2004) 1.63

Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses. Transplantation (2007) 1.56

Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants. J Virol (2005) 1.54

DNA polymerase theta contributes to the generation of C/G mutations during somatic hypermutation of Ig genes. Proc Natl Acad Sci U S A (2005) 1.53

Strategy for affinity maturation of an antibody with high evolvability to (4-hydroxy-3-nitrophenyl) acetyl hapten. Mol Immunol (2006) 1.46

Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Int J Oncol (2007) 1.41

In-vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo. Nat Commun (2011) 1.41

Two waves of memory B-cell generation in the primary immune response. Int Immunol (2005) 1.36

Repression of the transcription factor Bach2 contributes to predisposition of IgG1 memory B cells toward plasma cell differentiation. Immunity (2013) 1.36

Identification of a novel plant MAR DNA binding protein localized on chromosomal surfaces. Plant Mol Biol (2004) 1.35

Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway. PLoS Pathog (2008) 1.27

Cutting edge: CD28-mediated transcriptional and posttranscriptional regulation of IL-2 expression are controlled through different signaling pathways. J Immunol (2004) 1.24

Development of Th1 and not Th2 immune responses in mice lacking IFN-regulatory factor-4. Int Immunol (2003) 1.22

A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS). J Exp Med (2003) 1.11

A role of suppressor of cytokine signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated interleukin 2 production. J Exp Med (2003) 1.11

Evidence of allosteric conformational changes in the antibody constant region upon antigen binding. Int Immunol (2003) 1.05

Mycotic pseudoaneurysm of the ascending aorta caused by Escherichia coli. Interact Cardiovasc Thorac Surg (2012) 1.05

Unique biological properties of catalytic domain directed human anti-CAIX antibodies discovered through phage-display technology. PLoS One (2010) 1.03

Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28-mediated costimulation. J Immunol (2006) 1.02

Down-regulation of ICOS ligand by interaction with ICOS functions as a regulatory mechanism for immune responses. J Immunol (2008) 1.02

ICOS-mediated costimulation on Th2 differentiation is achieved by the enhancement of IL-4 receptor-mediated signaling. J Immunol (2005) 1.00

Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation. J Immunol (2002) 0.99

SS-A/Ro52, an autoantigen involved in CD28-mediated IL-2 production. J Immunol (2003) 0.99

Regulated costimulation in the thymus is critical for T cell development: dysregulated CD28 costimulation can bypass the pre-TCR checkpoint. J Immunol (2005) 0.98

Thermodynamic and kinetic aspects of antibody evolution during the immune response to hapten. Mol Immunol (2003) 0.98

PI3-kinase and MAP-kinase signaling cascades in AILIM/ICOS- and CD28-costimulated T-cells have distinct functions between cell proliferation and IL-10 production. Biochem Biophys Res Commun (2003) 0.97

Dynamical regulations of protein-ligand bindings at single molecular level. Biochem Biophys Res Commun (2007) 0.95

Novel role of the Ras cascade in memory B cell response. Immunity (2005) 0.95

Cloning, expression, and characterization of the superantigen streptococcal pyrogenic exotoxin G from Streptococcus dysgalactiae. Infect Immun (2007) 0.95

PHB2 protects sister-chromatid cohesion in mitosis. Curr Biol (2007) 0.94

Kinetic study of the enzymatic cycling reaction conducted with 3alpha-hydroxysteroid dehydrogenase in the presence of excessive thio-NAD(+) and NADH. Anal Biochem (2004) 0.94

Augmented antibody response with premature germinal center regression in CD40L transgenic mice. J Immunol (2010) 0.94

Normal immunoglobulin gene somatic hypermutation in Pol kappa-Pol iota double-deficient mice. Immunol Lett (2004) 0.94

Strict de novo methylation of the 35S enhancer sequence in gentian. PLoS One (2010) 0.93

Up-regulation of IL-4 production by the activated cAMP/cAMP-dependent protein kinase (protein kinase A) pathway in CD3/CD28-stimulated naive T cells. Int Immunol (2004) 0.93

Exploring the energy landscape of antibody-antigen complexes: protein dynamics, flexibility, and molecular recognition. Biochemistry (2008) 0.92

A familial case of visceral toxocariasis due to consumption of raw bovine liver. Parasitol Int (2008) 0.92

Conformational changes in the antibody constant domains upon hapten-binding. Mol Immunol (2005) 0.90

Protein dynamics and the diversity of an antibody response. J Biol Chem (2012) 0.89

Are there any real Helicobacter pylori infection-negative gastric cancers in Asia? Asian Pac J Cancer Prev (2007) 0.89

Metal-ion-dependent GFP emission in vivo by combining a circularly permutated green fluorescent protein with an engineered metal-ion-binding coiled-coil. J Am Chem Soc (2007) 0.88

Critical contribution of CD28-CD80/CD86 costimulatory pathway to protection from Trypanosoma cruzi infection. Infect Immun (2003) 0.88

The absence of DNA polymerase kappa does not affect somatic hypermutation of the mouse immunoglobulin heavy chain gene. Immunol Lett (2003) 0.87

RBMX: a regulator for maintenance and centromeric protection of sister chromatid cohesion. Cell Rep (2012) 0.87

CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis. Int Immunol (2008) 0.87

Segmental flexibility and avidity of IgM in the interaction of polyvalent antigens. Mol Immunol (2004) 0.86

Thermodynamic analysis of interactions between cofactor and neuronal nitric oxide synthase. Biochemistry (2011) 0.86

Midkine promoter-based conditionally replicative adenovirus for malignant glioma therapy. Oncol Rep (2004) 0.85

Induction of antitumor immune response by homeostatic proliferation and CD28 signaling. J Immunol (2008) 0.85

Transient-phase kinetic studies on the nucleotide binding to 3alpha-hydroxysteroid dehydrogenase from Pseudomonas sp. B-0831 using fluorescence stopped-flow procedures. Eur J Biochem (2004) 0.85

Multifocal encephalopathy and autoimmune-mediated limbic encephalitis following tocilizumab therapy. Intern Med (2014) 0.85

A novel Ca²⁺-activated, thermostabilized polyesterase capable of hydrolyzing polyethylene terephthalate from Saccharomonospora viridis AHK190. Appl Microbiol Biotechnol (2014) 0.84

Involvement of ICOS-B7RP-1 costimulatory pathway in the regulation of immune responses to Leishmania major and Nippostrongylus brasiliensis infections. Immunol Lett (2003) 0.84

Estimation of the relative affinity of B cell receptor by flow cytometry. J Immunol Methods (2003) 0.84

Both mutated and unmutated memory B cells accumulate mutations in the course of the secondary response and develop a new antibody repertoire optimally adapted to the secondary stimulus. Int Immunol (2013) 0.84

DNA polymerase eta is a limiting factor for A:T mutations in Ig genes and contributes to antibody affinity maturation. Eur J Immunol (2008) 0.84

Ex vivo-expanded DCs induce donor-specific central and peripheral tolerance and prolong the acceptance of donor skin grafts. Blood (2011) 0.84

Optimization of ex vivo activation and expansion of macaque primary CD4-enriched peripheral blood mononuclear cells for use in anti-HIV immunotherapy and gene therapy strategies. J Acquir Immune Defic Syndr (2003) 0.84

Molecular characterization of endo-1,3-β-glucanase from Cellulosimicrobium cellulans: effects of carbohydrate-binding module on enzymatic function and stability. Biochim Biophys Acta (2011) 0.83

Evaluation of the conformational equilibrium of reduced hen egg lysozyme by antibodies to the native form. Arch Biochem Biophys (2009) 0.83

[Subclavian steal syndrome associated with the right aortic arch in a patient with Peutz-Jeghers syndrome: case report]. No Shinkei Geka (2003) 0.83

Negative regulation of the SH2-homology containing protein-tyrosine phosphatase-1 (SHP-1) P2 promoter by the HTLV-1 Tax oncoprotein. Blood (2007) 0.83

Contribution of a single hydrogen bond between betaHis81 of MHC class II I-E(k) and the bound peptide to the pH-dependent thermal stability. Microbiol Immunol (2004) 0.83

Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody can prevent rat cardiac allograft rejection. J Heart Lung Transplant (2008) 0.83

Comparison of two different nutritive conditions against the changes in peripheral blood mononuclear cells of periparturient dairy cows. J Vet Med Sci (2006) 0.83

Introduction of wild-type p53 enhances thrombospondin-1 expression in human glioma cells. Cancer Lett (2003) 0.82

Glutathione-S-transferase P1-1 protects aberrant crypt foci from apoptosis induced by deoxycholic acid. Gastroenterology (2004) 0.81

Influence on the suicide rate two years after a devastating disaster: a report from the 1995 Great Hanshin-Awaji Earthquake. Psychiatry Clin Neurosci (2009) 0.81

Combination effect of mycophenolate mofetil with mizoribine on cell proliferation assays and in a mouse heart transplantation model. Transplantation (2006) 0.81

The effect of the side chain length of Asp and Glu on coordination structure of Cu(2+) in a de novo designed protein. Biopolymers (2009) 0.81

In vivo selection of CD4(+) T cells transduced with a gamma-retroviral vector expressing a single-chain intrabody targeting HIV-1 tat. Hum Gene Ther (2012) 0.81

AP-1 is involved in ICOS gene expression downstream of TCR/CD28 and cytokine receptor signaling. Eur J Immunol (2012) 0.81

Suppression of Con A-induced hepatitis induction in ICOS-deficient mice. Immunol Lett (2009) 0.81

High resolution crystal structure of the Grb2 SH2 domain with a phosphopeptide derived from CD28. PLoS One (2013) 0.81

Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice. Transplantation (2003) 0.81

A distinct role for ICOS-mediated co-stimulatory signaling in CD4+ and CD8+ T cell subsets. Int Immunol (2005) 0.81

Identification of CMTM7 as a transmembrane linker of BLNK and the B-cell receptor. PLoS One (2012) 0.81

Structure of beta-glucan oligomer from laminarin and its effect on human monocytes to inhibit the proliferation of U937 cells. Biosci Biotechnol Biochem (2005) 0.81

Epigenetic modifications of the 35S promoter in cultured gentian cells. Plant Sci (2011) 0.80

Crystal structures of hereditary vitamin D-resistant rickets-associated vitamin D receptor mutants R270L and W282R bound to 1,25-dihydroxyvitamin D3 and synthetic ligands. J Med Chem (2013) 0.80